3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
138
Prostatic Neoplasms
15
Lung Neoplasms
10
Colorectal Neoplasms
10
Motor Activity
8
Ovarian Neoplasms
7
Gastrointestinal Neoplasms
7
Neoplasms
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Lymphoma
4
Endometrial Neoplasms
4
Depression
4
Pain
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Fatigue
3
Colonic Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Anxiety Disorders
3
Vomiting
2
Thyroid Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Leukemia
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Communication
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Carcinoma In Situ
2
Interventions
liposomal doxorubicin
1
Vinorelbine
1
Surveys and Questionnaires
1
Prophylactic Mastectomy
1
Docetaxel
1
Cognitive Behavioral Therapy
1
Cephalexin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genetic Predisposition to Disease
×
Surveys and Questionnaires
×
Breast
×
Clear all
NCT04145817
2025-11-24
BRIDGEScohort2
Institut Curie
Phase NA
Completed
405 enrolled